UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K/A-1

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 29, 2021

SELECTIS HEALTH, INC.

(Exact Name of Registrant as Specified in its Charter)

Utah 0-15415 87-0340206

(State or other jurisdiction

of incorporation)

Commission

File Number

(I.R.S. Employer

Identification number)

8480 E. Orchard Road, Ste. 4900, Greenwood Village, CO 80111

(Address of principal executive offices)

(Zip Code)
Registrant's telephone number, including area code: (720)680-0808

(Former name or former address, if changed since last report)

Written communications pursuant to Rule 425 under the Securities Act
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

Securities registered pursuant to Section 12(b) of the Act:

Title of each ClassTrading Symbol

Name of each exchange on which registered

N/A N/A N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
ITEM 5.02RESCISSION OF COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS

On December 30, 2021, Selectis Health, Inc., announced the grant of Restricted Stock Units ("RSU") to certain of its officers. The RSU's were issued under the Company's 2021 Deferred Compensation and Equity Award Plan which was adopted effective July 1, 2021 (the "Plan").

After further consideration, the Company and the grantees of such RSU's, Lance Baller and Randy Barker, have agreed to rescind those grants.

ITEM 9.01:EXHIBITS
Item Title
4.4 Rescission Agreement
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Selectis Health, Inc.
(Registrant)
Dated: January 03, 2022/s/ Lance Baller
Lance Baller, CEO

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Selectis Health Inc. published this content on 03 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 January 2022 11:38:06 UTC.